Appili Therapeutics Statistics

Total Valuation

TSX:APLI has a market cap or net worth of CAD 1.82 million. The enterprise value is 12.89 million.

Market Cap	1.82M
Enterprise Value	12.89M

Important Dates

The last earnings date was Thursday, June 26, 2025.

Earnings Date	Jun 26, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:APLI has 121.27 million shares outstanding.

Current Share Class	121.27M
Shares Outstanding	121.27M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	n/a
Float	106.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.11
PB Ratio	-0.14
P/TBV Ratio	n/a
P/FCF Ratio	2.10
P/OCF Ratio	2.09
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.91
EV / Sales	128.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	14.87

Financial Position

The company has a current ratio of 0.19

Current Ratio	0.19
Quick Ratio	0.18
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	14.19
Interest Coverage	-3.42

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-278.71%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	79.65%
Revenue Per Employee	14,349
Profits Per Employee	-374,956
Employee Count	7
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, TSX:APLI has paid 18,830 in taxes.

Income Tax	18,830
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.50% in the last 52 weeks. The beta is -0.47, so TSX:APLI's price volatility has been lower than the market average.

Beta (5Y)	-0.47
52-Week Price Change	-62.50%
50-Day Moving Average	0.02
200-Day Moving Average	0.03
Relative Strength Index (RSI)	44.06
Average Volume (20 Days)	58,060

Short Selling Information

The latest short interest is 12,229, so 0.01% of the outstanding shares have been sold short.

Short Interest	12,229
Short Previous Month	47,047
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:APLI had revenue of CAD 100,443 and -2.62 million in losses. Loss per share was -0.02.

Revenue	100,443
Gross Profit	100,443
Operating Income	-10.09M
Pretax Income	-2.61M
Net Income	-2.62M
EBITDA	-10.07M
EBIT	-10.09M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 1.23 million in cash and 12.29 million in debt, giving a net cash position of -11.07 million or -0.09 per share.

Cash & Cash Equivalents	1.23M
Total Debt	12.29M
Net Cash	-11.07M
Net Cash Per Share	-0.09
Equity (Book Value)	-13.40M
Book Value Per Share	-0.11
Working Capital	-12.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 868,816 and capital expenditures -2,360, giving a free cash flow of 866,456.

Operating Cash Flow	868,816
Capital Expenditures	-2,360
Free Cash Flow	866,456
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-10,040.58%
Pretax Margin	-2,594.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	862.63%

Dividends & Yields

TSX:APLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-144.29%
FCF Yield	47.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:APLI has an Altman Z-Score of -48.91 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-48.91
Piotroski F-Score	4